Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
1618P Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304)
Anis Hamid, Heidi Thomas, A. Martín, Y.Y. Soon, Lisa G. Horvath, R. Zielinski, Alastair Thomson, Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Francis Parnis, Ray McDermott, Nicola Jane Lawrence, M. Frydenberg, K.N. Chi, Martin R. Stockler, I.D. Davis, C. Sweeney (2024). 1618P Clinical prognostic factors within the high volume subgroup of metastatic hormone sensitive prostate cancer (mHSPC) in ENZAMET (ANZUP 1304). , 35, DOI: https://doi.org/10.1016/j.annonc.2024.08.1699.
Article168 days agoOverall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial
Michael S. Hofman, Louise Emmett, Shahneen Sandhu, Amir Iravani, James Buteau, Anthony M. Joshua, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Siobhan Ng, Roslyn J. Francis, Craig Gedye, Natalie Rutherford, Andrew Weickhardt, Andrew M. Scott, Sze-Ting Lee, Edmond M. Kwan, Arun Azad, Shakher Ramdave, Andrew D. Redfern, W A Macdonald, Alex Guminski, Edward Hsiao, Wei Chua, Peter Lin, Alison Yan Zhang, Martin R. Stockler, Scott Williams, Andrew Martin, Ian D. Davis, Tim Akhurst, Ramin Alipour, Dale L. Bailey, Patricia Banks, Alexis Beaulieu, Louise Campbell, Megan Crumbaker, Nattakorn Dhiantravan, Anis Hamid, Mohammad B. Haskali, Terry Hung, Grace Kong, Nick Lawrence, Jeremy Lewin, Michael McCarthy, Kate Moodie, Declan G. Murphy, Andrew Nguyen, David Pook, Aravind Ravi Kumar, Paul Roach, Peter Roselt, Javad Saghebi, Geoffrey Schembri, Lavinia Spain, Shalini Subramaniam, Sue Ping Thang, Paul Thomas, Ben Tran, Roslyn E. Wallace, Sonia Yip (2023). Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial. , 25(1), DOI: https://doi.org/10.1016/s1470-2045(23)00529-6.
Article168 days agoDetection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer
Santosh Gupta, Luisa Fernandez, David Bourdon, Anis Hamid, Anupama Pasam, Ernest W.N. Lam, Rick Wenstrup, Shahneen Sandhu (2024). Detection of PSMA expression on circulating tumor cells by blood-based liquid biopsy in prostate cancer. , 13(1), DOI: https://doi.org/10.33393/jcb.2024.2636.
Article168 days agoLuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC).
Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Megan Crumbaker, Mathias Bressel, Rhonda Huynh, Patricia Banks, Roslyn Wallace, Anis Hamid, Andrisha Jade Inderjeeth, Ben Tran, Arun Azad, Ramin Alipour, Grace Kong, Aravind Ravi Kumar, Javad Saghebi, Scott Williams, Timothy Akhurst, Rodney J. Hicks, Michael S. Hofman (2023). LuPARP: Phase 1 trial of 177Lu-PSMA-617 and olaparib in patients with metastatic castration resistant prostate cancer (mCRPC).. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.5005.
Article168 days agoCirculating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.
Anis Hamid, Santosh Gupta, Shivakumar Keerthikumar, Anupama Pasam, Megan Crumbaker, Anthony M. Joshua, Ernest W.N. Lam, Rick Wenstrup, Louise Emmett, David L. Goode, Michael S. Hofman, Shahneen Sandhu (2023). Circulating tumor cells (CTCs) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with olaparib plus <sup>177</sup>lutetium-prostate specific membrane antigen-617 (<sup>177</sup>Lu-PSMA-617) in the LuPARP trial.. , 41(16_suppl), DOI: https://doi.org/10.1200/jco.2023.41.16_suppl.5064.
Article168 days ago